![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premier Veterinary Group Plc | LSE:PVG | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.50 | 32.00 | 37.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAKT
RNS Number : 5202T
Ark Therapeutics Group PLC
07 December 2011
Ark Therapeutics Group plc
Director's Share Dealing
Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that it was informed on 6 December by Mr Peter Keen, a Non-Executive Director of Ark, that he had transferred 11,765 ordinary shares of 1p each in the Company into a Self Invested Personal Pension ("SIPP"). Accordingly, on 6 December, 11,765 ordinary shares were sold by Mr Keen at a price of 3.85 pence per share and 11,765 ordinary shares were bought by the SIPP at the price of 3.85 pence per share.
Following these transactions, there has been no change in Mr Keen's interest in the Company's ordinary shares.
For further information please contact:
Ark Therapeutics Group plc +44 (0)20 7388 7722 Dr Edward Bliss, Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBBBDDRSGBGBR
1 Year Premier Veterinary Chart |
1 Month Premier Veterinary Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions